R EMAINING YEARS OF LIFE VARY
widely in older adults, and physicians should consider life expectancy when assessing goals ofcareandtreatmentplans. 1 However,life expectancy based on age and sex alone provideslimitedinformationbecausesurvivalisalsoinfluencedbyhealthandfunctional abilities. 2 There are currently no well-established approaches to predictinglifeexpectancythatincorporatehealth and function, although several models havebeendevelopedfromindividualdata sources. [3] [4] [5] Gait speed, also often termed walking speed, has been shown to be associated with survival among older adults in individual epidemiological cohort studies [6] [7] [8] [9] [10] [11] [12] and has been shown to reflect health and functional status. 13 Gait speed has been recommended as a potentially useful clinical indicator of well-being among the older adults. 14 The purpose of this study is to evaluate the association of gaitspeedwithsurvivalinolderadultsand to determine the degree to which gait speed explains variability in survival after accounting for age and sex.
METHODS

Overview
We used individual participant data from 9 cohort studies, baseline data for which were collected between 1986 and 2000 (TABLE 1) . 8, 15, 16, [18] [19] [20] [21] [22] [23] Each study, which included more than 400 older adults with gait speed data at baseline, monitored survival for at least 5 years. Analyses performed herein were conducted in 2009 and 2010. All studies required written informed consent and institutional review board approval.
Populations
All studies recruited communitydwelling older adults. Although some sought representative samples, 8, 15, 20, 23 others focused on healthier participants, 16, 17 single sex, 19, 22 or older adults from primary care practices. 21 Only
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Measures
Gait speed was calculated for each participant using distance in meters and time in seconds. All studies used instructions to walk at usual pace and from a standing start. The walk distance varied from 8 ft to 6 m. For 8 ft, we converted to 4-m gait speed by formula. 24 For 6 m, we created a conversion formula (4-m speed=−0.0341ϩ(6-m speed)ϫ0.9816 with R 2 =0.93, based on a cohort of 61 individuals with concurrent 4-and 6-m walks). For 15 feet (4.57 m), 23 speed was simply meters divided by time. Where available, data on fast gait speed (walk as fast as comfortably able 25 ) and the Short Physical Performance Battery were obtained. 26 Survival for each individual used study monitoring methods, including the National Death Index and individual study follow-up. Time from gait speed baseline to death was calculated in days. Five-year survival status was confirmed for more than 99% of participants.
Additional variables include sex, age, race/ethnicity (white, black, Hispanic, other,definedbyparticipant),height(centimeters), weight (kilograms), body mass index (BMI), calculated as weight in kilograms divided by height in meters squared (Ͻ25, 25-30, and Ͼ30), smoking (never, past, current), use of mobilityaids(none,cane,walker),systolicblood pressure, self-reports of health (excellent or very good vs good, fair, or poor), hospitalization in the past year (yes/no), and physician-diagnosed medical conditions (cancer, arthritis, diabetes, and heart disease,allyes/no).Measuresofself-reported functional status were not collected in all studies and varied in content and form. Wecreatedadichotomousvariablereflecting dependence in basic activities of daily living(ADLs)basedonreportofbeingunable or needing help from another person to perform any basic activity, including eating, toileting, hygiene, transfer, bathing, and dressing. For individuals independent in ADLs, we created a dichotomous variable reflecting difficulty in instrumental ADLs based on report of difficulty or dependence with shopping, meal preparation, or heavy housework due to a health or physical problem. Participants were then classified into 1 of 3 groups; dependent in ADLs, difficulty with instrumental ADLs, or independent. Physical activity data were collected in 6 studies, but time frames and items varied widely. Two studies used the Physical Activity Scale for the Elderly (PASE). 27 We dichotomizedthePASEscoreat100. 28 We created operational definitions of other covariatesthatwerereasonablyconsistent across studies. Covariates were identical forheight,weight,BMI,andsystolicblood pressure. Hospitalization within the prior yearwasdeterminedlargelybyself-report, andchronicconditionswerebyself-report of physician diagnosis, with heart disease encompassingangina,coronaryarterydisease, heart attack, and heart failure.
Statistical Analysis
Descriptive statistics summarized participant characteristics, follow-up period, and median survival from baseline. A study-wide a priori P value of .002 provides a conservative Bonferroni correction accounting for at least 25 individual statistical comparisons. Kaplan-Meier product-limit survival curves graphically summarize lifetimes for each gait speed category. 29 For graphical purposes, gait speed was categorized into 0.2-m/s increments with lower and upper extremes being grouped as less than 0.4 m/s and higher than 1.4 m/s.
Cox proportional hazards regression models were used to assess associations between gait speed and survival, adjusting for age at baseline, for which hazard ratios (HRs) correspond to a 0.1-m/s difference in gait speed. The analyses were repeated adjusting for height, sex, race, BMI, smoking history systolic blood pressure, diseases, prior hospitalization, and selfreported heath. Proportionality of hazards was verified by examining Schoenfeld residual plots. 30 Appropriateness of using gait speed as a continuous predictor was confirmed by observing linearity in Cox models with ordered 0.2-m/s gait speed categories. To examine the influence of early deaths, we repeated analyses excluding deaths within 1 year of gait speed measurement and moved up the 0 time for survival assessment (results were similar; eTable 1 available at http://www .jama.com). Subgroup analyses were repeated in strata by age (65-74, 75-84, or Ն85 years), sex, race, self-reported health status, smoking history, BMI, functional status, use of mobility aids, and hospitalization and by report of cancer, arthritis, diabetes, and heart disease. 29 Results were pooled across sex because no substantial sex differences existed in HRs within subgroup strata.
To obtain simple and clinically usable estimates of survival probability based on sex, age, and gait speed, we fit logistic regression models separately for each sex with dichotomized 5-and 10-year survival as the response variable and age, gait speed, and their interaction as continuous predictors. To obtain estimates of median survival (further life expectancy), we fit Weibull accelerated failure-time models separately for each with time to death as the response variable, and age, gait speed, and their interaction as continuous predictors. To compare ability to predict survival among candidate variables and to determine whether gait speed improves predictive accuracy beyond other clinical measures, we fit logistic regression models with dichotomized 5-year or 10-year survival as the response variable and various combinations of predictors as independent variables with both linear and squared terms for BMI. The area under the receiver operating characteristic (ROC) curve or C statistic was used as a measure predictive of accuracy for mortality. All study-specific statistical analyses were performed using SAS version 9.2 (SAS Institute Inc, Cary, North Carolina).
Age-adjusted HRs were pooled from all studies using standard meta-analytic statistical methodology. Heterogeneity of HRs across studies was assessed using the Q and I 2 statistics. 31, 32 We used a randomeffects model to appropriately pool the HRs on the log scale while incorporating any heterogeneity among study estimates andthentransformbacktoobtainanoverall HR, along with a 95% confidence interval (CI) and P value. 33 Sensitivity of the results was assessed by fitting a shared frailty 34 (unrelated to the geriatric syndromefrailty)modeltoindividualparticipant data with a ␥-distributed frailty parametertoaccountforstudyeffect(results similar; not shown). 34, 35 Five-and 10-year pointwise survival rates from the KaplanMeier curves for each sex, age-group, and gait speed category combination were pooled across studies using a randomeffects model on the complementary loglogscale 36 andthenappropriatelyinverted to obtain overall estimates of survival, as presented in the tables. We further used thestandardrandomeffectsmeta-analytic model to combine sex-specific regression coefficients for age, gait speed, and their interaction from logistic regression models for 5-and 10-year survival and used theoverallestimatestoconstructclinically usable survival probability nomograms; combine sex-specific regression coefficients for age, gait speed, and their interaction from accelerated failure time models for time to death and used the overall estimatestoconstructclinicallyusablelifeexpectancy nomograms; and combine areas under ROC curves obtained from 9 studies. An increase of 0.025 in overall area under ROC curve was interpreted as clinicallyrelevantbetteraccuracy. 37 Toappropriatelycombineentiresurvivalcurves across the 9 studies, we used the generalizedleastsquaresmethodforjointanalysisofsurvivalcurves. 38 Weusedarandomeffects model with weights obtained by inverseofthevarianceofthesurvivalfunctionatthemedianlifetimestopoolthemediansurvivaltimesforeachsex,agegroup, and gait speed category. We used ComprehensiveMetaAnalysisversion2.2(Biostat Inc, Englewood, New Jersey) for all meta-analytic methods and Stata SE 8 (StataCorp,CollegeStation,Texas)forfitting shared frailty models.
RESULTS
The 9 participating studies contributed a total of 34 485 participants (Table 1) . Although most studies included men and women, 2 were sex specific. 19, 22 Of the total, 59.6% were women. There were substantial numbers of African American (n=3852) and Hispanic (n=2650) participants. The studies had a wide age range, including 1765 persons older than 85 years. Similarly, there was a wide range of gait speeds, from less than 0.4 m/s (n=1247) to more than 1.4 m/s (n=1491). Study follow-up time ranged from 6.0 to 21.0 years, with participants followed up for a mean of 12.2 and a medianof13.8years.Therewere17 528total deaths across all studies, with rates varying from 18.40% to 91.87% in individual studies. Mortality rates appear to be related to length of follow-up (Table 1) .
To assess consistency across studies, risk of death was estimated per 0.1-m/s higher gait speed. Age-adjusted HRs by study ranged from 0.83 to 0.94 and all were significant (PϽ.001; FIGURE 1). We also examined the survival HRs for gait speed by study in subgroups, including age, sex, race/ethnicity, BMI, smoking history, use of mobility aids, prior hospitalization, self-reported health, functional status, and selected chronic diseases. There were consistent associations across studies, although given the large sample sizes, Q statistics were often statistically significant (details available in eFigure 1A-M available at http://www .jama.com). For the 3 levels of functional status (independent, difficulty with instrumental ADLs, and dependent in ADLs), the pooled HR per 0.1-m/s increase in gait speed for those who were independent was 0.92 (P=.005), for those with difficulty in instrumental activities was also 0.92 (PϽ.001) but was 0.94 (P=.02) among those dependent in ADLs. Because physical activity measures were not sufficiently consistent across studies, effects could not be pooled. The Osteoporotic Fractures in Men (MrOS) 19 and Hispanic Established Populations for Epidemiologic Studies of the Elderly (EPESE) 8 used the Physical Activity Scale for the Elderly (PASE). When dichotomized at a score of 100 into low and high activity, MrOS had consistent and statistically significant HRs for low (HR, 0.85; 95% CI, 0.81-0.88) and high (HR, 0.87; 95% CI, 0.84-0.90) physical activity. In the Hispanic EPESE, the HR for low physical activity was significant (0.92; 95% CI, 0.88-0.96) but the HR for higher physical activity was not (0.99; 95% CI, 0.95-1.04).Pooled HRs for all subgroups except functional status were consistently in the range of 0.81 to 0.92 and all were significant (P Ͻ .002).
The overall HR for survival per each 0.1 m/s faster gait speed was 0.88 (95% sented with age as a continuous variable). Gait speed was associated with differences in the probability of survival at all ages in both sexes, but was especially informative after age 75 years. In men, the probability of 5-year survival at age 85 ranged from 0.3 to 0.88 (eFigure 3A) and the probability of 10-year survival at age 75 years ranged from 0.18 to 0.86 (eFigure 4A). In women, the probability of 5-year survival remained greater than 0.5 until advanced age (eFigure 3B), but 10-year survival at age 75 years ranged from 0.34 to 0.92 and at age 80 years from 0.22 to 0.86 (eFigure 4B). Stratification by sex-specific median height failed to show systematic differences in survival rates between short and tall participants, so results presented are not stratified by height. Stratification by race/ethnicity (non-Hispanic white, black, Hispanic) suggested generally similar survival rates by gait speed among age and sex groups. Confidence intervals were often wide. In some subsets of slow walkers of Hispanic descent, survival rates were 10% to 20% higher than in other groups (eTable 2). We also used our analyses to estimate median years of remaining life based on sex, age, and gait speed. (FIGURE 2 , predicted survival data are based on an accelerated failure time model with Weibull distribution, with age as a continuous variable, and eTable 3, data are derived from pooled Kaplan-Meier es- Abbreviations: CI, confidence interval; NE, not estimable due to small number of participants in categories. a Survival estimates are derived from individual study Kaplan-Meier survival estimates that are pooled across studies using random-effects models with inverse variance weighting. To compare the 5-year survival predictiveabilitybetweendemographicsand gait speed vs other combinations of variables, we used areas under the ROC curve (C statistics) in logistic regression models for individual studies and pooled across studies (TABLE 3) . Gait speed added substantially 37 to age and sex in 7 of the 9 studies and in the pooled analysis. C statistics for age, sex, and gait speed were greater than those for age, sex, and chronic diseases in 4 of 9 studies, approximately equivalent in 5 studies and inferior in no studies. C statistics for age, Abbreviations: ABC, Aging and Body Composition; BMI, body mass index, calculated as weight in kilograms divided by height in meters squared; BP, blood pressure; CHS, Cardiovascular Health Study; CI, confidence interval; EPESE, Established Populations for the Epidemiological Study of the Elderly; NA, not applicable; NHANES III, Third National Health and Nutrition Examination Survey; PEP, Predicting Elderly Performance. a Functional status was operationally defined for 3 levels: (1) activities of daily living (ADLs) dependence is defined as report of needing help from another person or being unable to perform any of 6 basic ADLs, 2) Instrumental ADL difficulty is defined as report of no ADL dependence but difficulty performing shopping, meal preparation, or heavy housework, and (3) Independent is defined as no report of ADL dependence or instrumental ADL difficulty. b Value is the pooled estimate of the area under the receiver operator characteristic curve for age, sex, and gait speed for the studies that were used in the comparisons of gait speed with use of mobility aids and functional status. Four studies were included in the estimates of 5 y mortality and three in the estimates of 10 y mortality. Values are reported as the C statistic representing area under the receiver operator characteristic curve; values that differ by 0.025 or more are considered substantially different.
Figure 2. Predicted Median Life Expectancy by Age and Gait Speed
sex, and gait speed were approximately equivalent to those for age, sex, chronic diseases, BMI, systolic blood pressure, and prior hospitalization in all 9 studies and in the pooled analysis. There were 4 studies that had sufficiently consistent data on functional status to create 3 categories: dependent in ADLs, difficulty with instrumental ADLs, and independent. For these studies, gait speed, age, and sex yielded a C statistic (0.741) that was not significantly different (P = .78) from age, sex, mobility aids, and functional status (P=.75; Table 3 ). For 10-year survival, 6 studies had sufficient follow-up time to perform many of the analyses (Table 3) . Gait speed added predictive ability to age and sex in 4 of 6 studies and in the pooled analysis. C statistics for age, sex, and gait speed were not significantly different from C statistics with all the other factors for any study nor for the pooled analysis. Three studies had sufficiently consistent data on functional status at baseline to allow pooling. Gait speed, age, and sex yielded a C statistic (0.734) that was not significantly different from age, sex, mobility aids, and functional status (0.732; (P=.95; Table 3 ).
In addition, we used C statistics to assess the ability of usual gait speed to predict survival compared with other physical performance measures, such as fast gait speed and the Short Physical Performance Battery (SPPB), a brief measure that includes walk speed, chair rise ability, and balance. We assessed usual vs fast gait speed in the single study with both measures (Invecciare in Chianti 
COMMENT
Gait speed, age, and sex may offer the clinician tools for assessing expected survival to contribute to tailoring goals of care in older adults. The accuracy of predictions based on these 3 factors appears to be approximately similar to more complex models involving multiple other health-related factors, or for age, sex, use of mobility aids, and functional status. Gait speed might help refine survival estimates in clinical practice or research because it is simple and informative.
Whywouldgaitspeedpredictsurvival? Walkingrequiresenergy,movementcontrol, and support and places demands on multiple organ systems, including the heart, lungs, circulatory, nervous, and musculoskeletalsystems.Slowinggaitmay reflect both damaged systems and a highenergy cost of walking. 13, [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] Gait speed could be considered a simple and accessiblesummaryindicatorofvitalitybecause itintegratesknownandunrecognizeddisturbancesinmultipleorgansystems,many of which affect survival. In addition, decreasing mobility may induce a vicious cycle of reduced physical activity and deconditioning that has a direct effect on health and survival. 6 The association between gait speed and survival is known. 6, 7, [9] [10] [11] [12] 55, 56 Prior analyses used single cohorts and presented results as relative rather than absolute risk, as done herein. Similarly, mortality prediction models have been developed. [3] [4] [5] [57] [58] [59] [60] Some models use selfreported information but others also include physiological or performance data, for a total of 4 to more than 10 predictive factors. Only a few models assess overall predictive capacity using C statistics; the reported values are in the range found in the present study (published area under the curve range, 0.66-0.82 61 vs this study, 0.717 and 0.737). The strengths of this study are the very largesampleofindividualparticipantdata from multiple diverse populations of community-dwellingelderswhowerefollowed up for many years and use of consistent measures of performance and outcome. We provide survival estimates for a broad range of gait speeds and calculate absolute rates and median years of survival.Comparedwithpriorstudiesthat were too small to assess potential effect modification by age, sex, race/ethnicity, and other subgroups, we were able to assessmultiplesubgroupeffectswithsubstantial power. This study has the limitations of observational research; it cannot establish causal relationships and is vulnerable to various forms of healthy volunteer bias. The participating study cohorts, while large and diverse, do not represent the universe of possible data. Oursurvivalestimatesshouldbevalidated in additional data sets. Only 1 of the 9 studies was based in clinical practice, 21 and advanced dementia is rare in populations who are competent to consent for research. However, median years of survival in this study resemble estimates for US adults across the sex and age range assessed. 62 We were unable to assess the association of physical activity with survival in pooled analyses because measures of activity were highly variable across studies. Also, participants in these studies had no prior knowledge about the meaning of walking speed. In clinical use, participants might walk differently if they are aware of the implications of the results. Although this study provides informationonsurvival,furtherworkisneeded to examine associations of other important pooled outcomes such as disability and health care use and to examine effects in populations more completely based in clinical practice.
Because gait speed can be assessed by nonprofessional staff using a 4-m walkway and a stopwatch, 21 it is relatively simple to measure compared with many medicalassessments.Nevertheless,methodologicalissuessuchasdistanceandverbal instructions remain. 63, 64 Self-report is an alternative to gait speed for reflecting function. However, significant challenges remain in the use of self-report as well, such as choice of items and reliability, someofwhichcanbeaddressedbyemerging techniques such as computer adaptive testing based on item-response theory. 65 The results found herein suggest that gait speed appears to be especially informative in older persons who report either no functional limitations or only difficulty with instrumental ADLs and may be less helpful for older adults who already report dependence in basic ADLs. The research studies analyzed herein used trained staff to measure gait speed.Staffinclinicalsettingswouldneed initial training and may produce more variableresults.Long-distancewalkshave become accepted in some medical fields and may contribute information beyond short walks. [66] [67] [68] However, the longer distance and time to perform the test may limit feasibility in many clinical settings. Although the sample size of very slow walkers was small, our data suggest that there may be a subpopulation who walk very slowly but survive for long periods. It would be valuable to further characterize this subgroup.
Although the gait speed-survival relationship seems continuous across the entire range, cut points may help interpretation. Several authors have proposed that gait speeds faster than 1.0 m/s suggest healthier aging while gait speeds slower than 0.6 m/s increase the likelihood of poor health and function. 7, 21 Others propose one cutoff around 0.8 m/s. 13 In our data, predicted life expectancy at themedianforageandsexoccursatabout 0.8 m/s; faster gait speeds predict life expectancy beyond the median. Perhaps a gait speed faster than 1.0 m/s suggests betterthanaveragelifeexpectancyandabove 1.2 m/s suggests exceptional life expectancy, but additional research will be necessary to determine this relationship.
How might gait speed be used clinically? First, gait speed might help identify older adults with a high probability of living for 5 or 10 more years, who may be appropriate targets for preventive interventions that require years for benefit. Second, gait speed might be used to identifyolderadultswithincreasedriskofearly mortality, perhaps those with gait speeds slower than 0.6 m/s. In these patients, further examination is targeted at potentially modifiable risks to health and survival. A recommended evaluation and management of slow walking includes cardiopulmonary, neurological and musculoskeletal systems. 6, 18 Third, gait speed might promote communication. Primary clinicians might characterize an older adult as likely to be in poor health and function because the gait speed is 0.5 m/s. In research manuscripts, baseline gait speed might help to characterize the overall health of older research participants. Fourth, gait speed might be monitored over time, with a decline indicating a new health problem that requires evaluation. Fifth, gait speed might be used to stratify risks from surgery or chemotherapy. Finally, medical and behavioral interventions might be assessed for their effect on gait speed in clinical trials. Such true experimentscouldthenevaluatecausalpathways to determine whether interventions that improve gait speed lead to improvements in function, health, and longevity.
The data provided herein are intended to aid clinicians, investigators, and health system planners who seek simple indicators of health and survival in older adults. Gait speed has potential to be implemented in practice, using a stop watch and a 4-m course. From a standing start, individuals are instructed to walk at their usual pace, as if they were walking down the street, and given no further encouragement or instructions. The data in this article can be used to help interpret the results. Gait speed may be a simple and accessible indicator of the health of the older person.
